Cargando…

Correction: Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337659/
https://www.ncbi.nlm.nih.gov/pubmed/28270934
http://dx.doi.org/10.1136/rmdopen-2016-000314corr1
_version_ 1782512412726919168
collection PubMed
description
format Online
Article
Text
id pubmed-5337659
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53376592017-03-07 Correction: Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA RMD Open Correction BMJ Publishing Group 2017-02-23 /pmc/articles/PMC5337659/ /pubmed/28270934 http://dx.doi.org/10.1136/rmdopen-2016-000314corr1 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Correction
Correction: Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA
title Correction: Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA
title_full Correction: Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA
title_fullStr Correction: Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA
title_full_unstemmed Correction: Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA
title_short Correction: Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA
title_sort correction: drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with tnfi: results from bsrbr-ra
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337659/
https://www.ncbi.nlm.nih.gov/pubmed/28270934
http://dx.doi.org/10.1136/rmdopen-2016-000314corr1